Astec Lifesciences Ltd Quarterly Results

Gross Sales

73.72

91.08

119.53

93.86

98.55

Excise Duty

0

0

0

0

0

Net Sales

73.72

91.08

119.53

93.86

98.55

Other Operating Income

0

0

0

0

0

Other Income

1.12

0.51

0.79

1.91

2

Total Income

74.84

91.59

120.32

95.77

100.54

Total Expenditure

80.41

102.07

114

99.6

118.28

PBIDT

-5.57

-10.48

6.32

-3.83

-17.74

Interest

8.4

11.04

10.4

9.92

9.33

PBDT

-13.97

-21.52

-4.08

-13.75

-27.07

Depreciation

10.44

11.49

11.58

11.4

11.47

Minority Interest Before NP

0

0

0

0

0

Tax

0.01

0.01

0.01

0.01

0.01

Deferred Tax

0

0

0.4

15.21

0

Reported Profit After Tax

-24.42

-33.03

-16.08

-40.37

-38.55

Minority Interest After NP

0.01

0.01

0.01

0.01

0.01

Net Profit after Minority Interest

-24.43

-33.04

-16.09

-40.38

-38.56

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

-24.43

-33.04

-16.09

-40.38

-38.56

EPS (Unit Curr.)

-11.35

-16.85

-8.2

-20.59

-19.66

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

22.28

19.61

19.61

19.61

19.61

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

-7.55

-11.5

5.28

-4.08

-18

PBDTM(%)

-18.95

-23.62

-3.41

-14.64

-27.46

PATM(%)

-33.12

-36.26

-13.45

-43.01

-39.11